Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Hemophilia A”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04131036
What this trial is testing

Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A

Who this might be right for
Hemophilia A
Washington Institute for Coagulation 40
Not applicableStudy completedNCT04165135
What this trial is testing

An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment

Who this might be right for
Severe Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHaemophilia A
Hoffmann-La Roche 103
Post-approval studies (Phase 4)Ended earlyNCT01811875
What this trial is testing

Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A

Who this might be right for
Haemophilia A
Bio Products Laboratory 7
Post-approval studies (Phase 4)Study completedNCT01128881
What this trial is testing

IMMUNINE Pre-Treatment Study

Who this might be right for
Hemophilia B
Baxalta now part of Shire 57
Not applicableStudy completedNCT00936312
What this trial is testing

Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study

Who this might be right for
Hemophilia AHemophilia B
Weill Medical College of Cornell University 200
Large-scale testing (Phase 3)Study completedNCT00243659
What this trial is testing

Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer 30
Not applicableNot Yet RecruitingNCT07582276
What this trial is testing

A Prospective Assessment of Bone Health in Patients With Severe Hemophilia A on Factor VIII vs Factor Mimetic Prophylaxis (Efa Emi Bone Health Study)

Who this might be right for
Hemophilia a
Arkansas Children's Hospital Research Institute 50
Not applicableEnrolling By InvitationNCT05768386
What this trial is testing

A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)

Who this might be right for
Hemophilia A
BioMarin Pharmaceutical 172
Large-scale testing (Phase 3)Study completedNCT03376516
What this trial is testing

Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Wilate in Previously Treated Paediatric Patients With Severe Haemophilia A

Who this might be right for
Severe Hemophilia A
Octapharma 11
Post-approval studies (Phase 4)Study completedNCT00916032
What this trial is testing

Pharmacokinetic Study of ADVATE 3000 IU in Previously Treated Patients With Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 29
Testing effectiveness (Phase 2)Study completedNCT03061201
What this trial is testing

Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A

Who this might be right for
Hemophilia A
Pfizer 13
Large-scale testing (Phase 3)Study completedNCT05817812
What this trial is testing

A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog Alfa

Who this might be right for
Hemophilia A, Severe
Swedish Orphan Biovitrum 93
Early research (Phase 1)Study completedNCT05493631
What this trial is testing

A Phase 1b Study to Assess the Safety, Tolerability, PK and PD of MG1113 in Hemophilia Patient

Who this might be right for
Hemophilia
GC Biopharma Corp 15
Not applicableUnknownNCT01505946
What this trial is testing

Thrombin Generation Assay (TGA) as Predictive Test for Haemostatic. Effectiveness of FVIII Concentrates in Haemophiliac A With Inhibitors

Who this might be right for
Severe Hemophilia A With Inhibitor
Grifols Italia S.p.A 25
Testing effectiveness (Phase 2)Ended earlyNCT00623727
What this trial is testing

BAY79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A

Who this might be right for
Hemophilia A
Bayer 143
Large-scale testing (Phase 3)Study completedNCT03417245
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 120
Early research (Phase 1)Study completedNCT01653639
What this trial is testing

Comparative Pharmacokinetic Study of Two Different Strengths of BAY14-2222

Who this might be right for
Hemophilia A
Bayer 18
Not applicableUnknownNCT02512250
What this trial is testing

Swiss Hemophilia Registry

Who this might be right for
Hemophilia and Other Severe Bleeding Disorders
Swiss Hemophilia Network 900
Large-scale testing (Phase 3)Study completedNCT04759131
What this trial is testing

Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A

Who this might be right for
Hemophilia A
Bioverativ, a Sanofi company 74
Not applicableStudy completedNCT04590950
What this trial is testing

Dosage and PD Study of Eftrenonacog-alfa

Who this might be right for
Severe Haemophilia B
Assistance Publique - Hôpitaux de Paris 15
Next Page